One of the most significant features of Serrapeptase is that it does not harm any living cells or tissues in the human body; it only dissolves non-living tissue such as cysts, hard and soft arterial plaque, blood clots, etc. The late Hans Nieper, MD, was a German physician that was well known for his use and study of proteolytic enzymes in the treatment of artherosclerosis. He called Serrapeptase the miracle enzyme after using ultrasound to measure its ability to effectively dissolve arterial plaque without harming healthy cells lining the arterial wall.
Studies conducted in Europe and Asia have shown that Serrapeptase is an effective anti-inflammatory, anti-edemic (reduces fluid retention) and fibrinolytic (dissolution of fibrin). In Japan, a clinical trial demonstrated that Serrapeptase was effective in reducing inflammation resulting from post-operative swelling. A study conducted in India demonstrated that Serrapeptase was effective in the treatment of Carpal Tunnel Syndrome. Italian researchers found that Serrapeptase was very effective in the treatment of varicose veins.
For the treatment of Lyme disease Lee Cowden, MD now uses Nutramedix Serrapeptase in place of Carnivora. The primary purpose of Serrapeptase in the Lyme disease protocol is to dissolve the fibrin layer surrounding harmful microbes associated with Lyme disease such as Borrelia, Babesia, Bartonella and Ehrlichia. The fibrin layer covering these microbes causes them to be hidden from the immune system; once the fibrin is dissolved the immune system can more easily identify and eliminate the harmful microbes.
There are many proteolytic enzymes currently available, but they are derived from allergenic sources like soy, pork and aspergillus; most patients will not be sensitive to Serrapeptase due to its hypo-allergenic source. Serrapeptase is also considered to be an effective, low cost thrombolytic and can also be used after meals to aid the digestion of animal sourced protein.
Some medical conditions that Serrapeptase is helpful in treating: